Simplify Asset Management’s AstraZeneca AZN Stock Holding History

Simplify Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.48M	Buy	34,188 +8,370	+32%	+$1.57M	0.09%	39
2026 Q1	$5.09M	Sell	25,818 -9,672	-27%	-$1.86M	0.08%	33
2025 Q4	$6.53M	Buy	35,490 +17,018	+92%	+$2.98M	0.11%	29
2025 Q3	$2.83M	Buy	18,472 +2,246	+14%	+$340K	0.05%	40
2025 Q2	$2.27M	Sell	16,226 -1,769	-10%	-$248K	0.11%	39
2025 Q1	$2.65M	Buy	+17,995	New	+$2.6M	0.1%	36

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Simplify Asset Management's AZN Position: Q2 2026 in Review

Simplify Asset Management increased its AstraZeneca (AZN) stake by 32% in Q2 2026, buying an estimated $1.57M and bringing the position to 34,188 shares worth $6.48M. The position accounts for 0.09% of the portfolio, ranked #39.

Simplify Asset Management first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.53M in Q4 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Simplify Asset Management held 34,188 shares of AstraZeneca worth $6.48M as of Q2 2026.
Simplify Asset Management bought 8,370 AstraZeneca shares in Q2 2026, an estimated $1.57M.
AstraZeneca made up 0.09% of Simplify Asset Management's portfolio in Q2 2026, its #39 holding.
Simplify Asset Management first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
Simplify Asset Management's AstraZeneca position peaked at $6.53M in Q4 2025.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.